ASX - By Stock
|
EZZ |
Re:
Ann: EZZ Completes Private Placement with Strategic Investor
|
|
Clivus
|
25 |
4.4K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
25
|
4.4K
|
1
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Half Yearly Report and Accounts
|
|
Clivus
|
20 |
3.8K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
20
|
3.8K
|
1
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Share Purchase Plan - Closing Date Reminder
|
|
Clivus
|
33 |
9.2K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
33
|
9.2K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Pointerra awarded contract from US energy utility customer
|
|
Clivus
|
51 |
23K |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
51
|
23K
|
5
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
Clivus
|
6 |
2.0K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Clivus
|
36 |
14K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
36
|
14K
|
6
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR FY24 Half Year Investor Presentation
|
|
Clivus
|
3 |
1.3K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Suspension from Quotation
|
|
Clivus
|
120 |
57K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
120
|
57K
|
3
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Suspension from Quotation
|
|
Clivus
|
120 |
57K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
120
|
57K
|
8
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Suspension from Quotation
|
|
Clivus
|
120 |
57K |
14 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
120
|
57K
|
14
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 1H24 Results Presentation
|
|
Clivus
|
71 |
28K |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
71
|
28K
|
2
|
|
ASX - By Stock
|
HCL |
Re:
Ann: HighCom CEO Resignation
|
|
Clivus
|
45 |
19K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
45
|
19K
|
0
|
|
ASX - By Stock
|
HCL |
Re:
Ann: HighCom Half Year Results Guidance
|
|
Clivus
|
40 |
14K |
6 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
40
|
14K
|
6
|
|
ASX - By Stock
|
HCL |
Re:
Ann: HighCom Half Year Results Guidance
|
|
Clivus
|
40 |
14K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
40
|
14K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Ann: Application for quotation of securities - HZR
|
|
Clivus
|
5 |
1.4K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|
ASX - By Stock
|
AVA |
Re:
Ann: Additional Information on Supply Agreement with Telstra
|
|
Clivus
|
11 |
3.6K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
2 |
1.1K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Q2 FY24 Quarterly Activities Report and Appendix 4C
|
|
Clivus
|
32 |
13K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
32
|
13K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Breakout Looming?
|
|
Clivus
|
351 |
153K |
4 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
351
|
153K
|
4
|
|
ASX - By Stock
|
VHT |
Re:
Ann: Volpara Health enters into scheme implementation agreement
|
|
Clivus
|
32 |
24K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
32
|
24K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
Clivus
|
95 |
28K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
95
|
28K
|
2
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Extension of Share Purchase Plan Closing Date
|
|
Clivus
|
68 |
21K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
68
|
21K
|
1
|
|
ASX - By Stock
|
KZR |
Re:
Ann: KZR Spin out - Kali Metals lodges Prospectus for 12m IPO
|
|
Clivus
|
45 |
16K |
1 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
45
|
16K
|
1
|
|
ASX - By Stock
|
ALC |
Re:
Peak pessimism - complete overreaction
|
|
Clivus
|
193 |
71K |
3 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
193
|
71K
|
3
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Trading Halt
|
|
Clivus
|
74 |
26K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
74
|
26K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
122 |
48K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
122
|
48K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to Recommence Trading
|
|
Clivus
|
10 |
4.1K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
10
|
4.1K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
122 |
48K |
8 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
122
|
48K
|
8
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Trading Halt
|
|
Clivus
|
74 |
26K |
6 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
74
|
26K
|
6
|
|
ASX - By Stock
|
SDV |
Re:
Ann: September 2023 Quarterly Report
|
|
Clivus
|
11 |
4.0K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
11
|
4.0K
|
1
|
|
ASX - By Stock
|
SDV |
Re:
Ann: September 2023 Quarterly Report
|
|
Clivus
|
11 |
4.0K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
Clivus
|
458 |
290K |
1 |
19/10/23 |
19/10/23 |
Charts
|
458
|
290K
|
1
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
23 |
8.6K |
3 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
23
|
8.6K
|
3
|
|
ASX - By Stock
|
EZZ |
Re:
Lodge Partners Research Update
|
|
Clivus
|
3 |
1.7K |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
ESK |
Re:
Ann: Etherstack signs agreement with Telstra for MCX IWF trial
|
|
Clivus
|
10 |
4.0K |
2 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
10
|
4.0K
|
2
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Preliminary Final Report
|
|
Clivus
|
36 |
14K |
6 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
36
|
14K
|
6
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Audited FY 2023 Financial Statements and App 4E
|
|
Clivus
|
14 |
4.9K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
14
|
4.9K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Audited FY 2023 Financial Statements and App 4E
|
|
Clivus
|
14 |
4.9K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
14
|
4.9K
|
1
|
|
ASX - By Stock
|
AVA |
Re:
Ann: Investor Presentation
|
|
Clivus
|
15 |
4.0K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
15
|
4.0K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
Clivus
|
19 |
11K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
19
|
11K
|
3
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Audited FY 2023 Financial Statements and App 4E
|
|
Clivus
|
14 |
4.9K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
14
|
4.9K
|
0
|
|
ASX - By Stock
|
SDV |
Re:
Ann: Audited FY 2023 Financial Statements and App 4E
|
|
Clivus
|
14 |
4.9K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
14
|
4.9K
|
0
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Clivus
|
1 |
834 |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
1
|
834
|
0
|
|
ASX - By Stock
|
BMT |
Re:
Ann: FY23 Results Announcement
|
|
Clivus
|
24 |
7.9K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
24
|
7.9K
|
0
|
|
ASX - By Stock
|
BMT |
Re:
Ann: FY23 Results Announcement
|
|
Clivus
|
24 |
7.9K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
24
|
7.9K
|
2
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
Clivus
|
29 |
12K |
2 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
SCL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
5 |
2.8K |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
5
|
2.8K
|
1
|
|
ASX - By Stock
|
SCL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
5 |
2.8K |
0 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clivus
|
73 |
15K |
0 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
73
|
15K
|
0
|
|
ASX - By Stock
|
DVP |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
Clivus
|
40 |
14K |
4 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
40
|
14K
|
4
|
|